Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuances
Ratios

Lifecore Biomedical (LFCR) Other Gross PP&E Adjustments: 2009-2025

Historic Other Gross PP&E Adjustments for Lifecore Biomedical (LFCR) over the last 6 years, with May 2025 value amounting to $186.4 million.

  • Lifecore Biomedical's Other Gross PP&E Adjustments fell 5.40% to $186.4 million in Q2 2025 from the same period last year, while for May 2025 it was $769.3 million, marking a year-over-year increase of 312.80%. This contributed to the annual value of $186.4 million for FY2025, which is 5.40% down from last year.
  • As of Q2 2025, Lifecore Biomedical's Other Gross PP&E Adjustments stood at $186.4 million, which was up 2.72% from $181.5 million recorded in Q1 2025.
  • Lifecore Biomedical's Other Gross PP&E Adjustments' 5-year high stood at $202.6 million during Q4 2024, with a 5-year trough of -$15.4 million in Q1 2021.
  • For the 3-year period, Lifecore Biomedical's Other Gross PP&E Adjustments averaged around $113.7 million, with its median value being $183.8 million (2023).
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first tumbled by 50.11% in 2021, then spiked by 7,330.60% in 2025.
  • Lifecore Biomedical's Other Gross PP&E Adjustments (Quarterly) stood at -$7.5 million in 2021, then rose by 29.87% to -$5.3 million in 2022, then increased by 23.14% to -$4.0 million in 2023, then surged by 5,120.89% to $202.6 million in 2024, then dropped by 5.40% to $186.4 million in 2025.
  • Its Other Gross PP&E Adjustments stands at $186.4 million for Q2 2025, versus $181.5 million for Q1 2025 and $202.6 million for Q4 2024.